163 related articles for article (PubMed ID: 2955539)
1. Hemorrhagic thrombocytopathy with platelet thromboxane A2 receptor abnormality: defective signal transduction with normal binding activity.
Ushikubi F; Okuma M; Kanaji K; Sugiyama T; Ogorochi T; Narumiya S; Uchino H
Thromb Haemost; 1987 Apr; 57(2):158-64. PubMed ID: 2955539
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the defective signal transduction mechanism through the platelet thromboxane A2 receptor in a patient with polycythemia vera.
Ushikubi F; Ishibashi T; Narumiya S; Okuma M
Thromb Haemost; 1992 Jan; 67(1):144-6. PubMed ID: 1535462
[TBL] [Abstract][Full Text] [Related]
3. Defective signal transduction through the thromboxane A2 receptor in a patient with a mild bleeding disorder: deficiency of the inositol 1,4,5-triphosphate formation despite normal G-protein activation.
Mitsui T; Yokoyama S; Shimizu Y; Katsuura M; Akiba K; Hayasaka K
Thromb Haemost; 1997 May; 77(5):991-5. PubMed ID: 9184416
[TBL] [Abstract][Full Text] [Related]
4. Binding of an 125I-labeled thromboxane A2/prostaglandin H2 receptor antagonist to washed canine platelets.
Mais DE; Kochel PJ; Saussy DL; Halushka PV
Mol Pharmacol; 1985 Aug; 28(2):163-9. PubMed ID: 2991736
[TBL] [Abstract][Full Text] [Related]
5. Defective signal transduction induced by thromboxane A2 in a patient with a mild bleeding disorder: impaired phospholipase C activation despite normal phospholipase A2 activation.
Fuse I; Mito M; Hattori A; Higuchi W; Shibata A; Ushikubi F; Okuma M; Yahata K
Blood; 1993 Feb; 81(4):994-1000. PubMed ID: 8428006
[TBL] [Abstract][Full Text] [Related]
6. Pathogenetic analysis of five cases with a platelet disorder characterized by the absence of thromboxane A2 (TXA2)-induced platelet aggregation in spite of normal TXA2 binding activity.
Fuse I; Hattori A; Mito M; Higuchi W; Yahata K; Shibata A; Aizawa Y
Thromb Haemost; 1996 Dec; 76(6):1080-5. PubMed ID: 8972034
[TBL] [Abstract][Full Text] [Related]
7. Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to washed human platelets.
Mais DE; Burch RM; Saussy DL; Kochel PJ; Halushka PV
J Pharmacol Exp Ther; 1985 Dec; 235(3):729-34. PubMed ID: 3001275
[TBL] [Abstract][Full Text] [Related]
8. Hypersensitivity to thromboxane A2 in cholesterol-rich human platelets.
Tomizuka T; Yamamoto K; Hirai A; Tamura Y; Yoshida S
Thromb Haemost; 1990 Dec; 64(4):594-9. PubMed ID: 2150728
[TBL] [Abstract][Full Text] [Related]
9. Platelet and vascular smooth muscle thromboxane A2/prostaglandin H2 receptors.
Halushka PV; Mais DE; Saussy DL
Fed Proc; 1987 Jan; 46(1):149-53. PubMed ID: 2948839
[TBL] [Abstract][Full Text] [Related]
10. [PI metabolism and Ca mobilization in patients with platelet dysfunction].
Fuse I; Hattori A; Higuchi W; Shibata A
Nihon Rinsho; 1992 Feb; 50(2):237-43. PubMed ID: 1535386
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of a dominantly inherited bleeding disorder with impaired platelet responses to thromboxane A2.
Okuma M; Hirata T; Ushikubi F; Kakizuka A; Narumiya S
Pol J Pharmacol; 1996; 48(1):77-82. PubMed ID: 9112632
[TBL] [Abstract][Full Text] [Related]
12. Thromboxane-insensitive dog platelets have impaired activation of phospholipase C due to receptor-linked G protein dysfunction.
Johnson GJ; Leis LA; Dunlop PC
J Clin Invest; 1993 Nov; 92(5):2469-79. PubMed ID: 8227362
[TBL] [Abstract][Full Text] [Related]
13. Distinct platelet thromboxane A2/prostaglandin H2 receptor subtypes. A radioligand binding study of human platelets.
Dorn GW
J Clin Invest; 1989 Dec; 84(6):1883-91. PubMed ID: 2531760
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic characterization of human and canine thromboxane A2/prostaglandin H2 receptors in platelets and blood vessels: evidence for different receptors.
Mais DE; Saussy DL; Chaikhouni A; Kochel PJ; Knapp DR; Hamanaka N; Halushka PV
J Pharmacol Exp Ther; 1985 May; 233(2):418-24. PubMed ID: 2987481
[TBL] [Abstract][Full Text] [Related]
15. Increased platelet thromboxane A2/prostaglandin H2 receptors in patients with acute myocardial infarction.
Dorn GW; Liel N; Trask JL; Mais DE; Assey ME; Halushka PV
Circulation; 1990 Jan; 81(1):212-8. PubMed ID: 2137044
[TBL] [Abstract][Full Text] [Related]
16. Functional reconstitution of platelet thromboxane A2 receptors with Gq and Gi2 in phospholipid vesicles.
Ushikubi F; Nakamura K; Narumiya S
Mol Pharmacol; 1994 Nov; 46(5):808-16. PubMed ID: 7969066
[TBL] [Abstract][Full Text] [Related]
17. Arachidonic acid-induced platelet aggregation is mediated by a thromboxane A2/prostaglandin H2 receptor interaction.
Parise LV; Venton DL; Le Breton GC
J Pharmacol Exp Ther; 1984 Jan; 228(1):240-4. PubMed ID: 6319669
[TBL] [Abstract][Full Text] [Related]
18. Mutations of the platelet thromboxane A2 (TXA2) receptor in patients characterized by the absence of TXA2-induced platelet aggregation despite normal TXA2 binding activity.
Higuchi W; Fuse I; Hattori A; Aizawa Y
Thromb Haemost; 1999 Nov; 82(5):1528-31. PubMed ID: 10595649
[TBL] [Abstract][Full Text] [Related]
19. [Measurement of platelet thromboxane A2/prostaglandin H2 receptor in asthmatic patients].
Hada S; Hashizume M; Yoshioka F; Nishii S; Yasunaga K
Arerugi; 1993 May; 42(5):609-16. PubMed ID: 8323459
[TBL] [Abstract][Full Text] [Related]
20. Castration reduces platelet thromboxane A2 receptor density and aggregability.
Ajayi AA; Halushka PV
QJM; 2005 May; 98(5):349-56. PubMed ID: 15820970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
